These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28145409)

  • 21. Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis.
    Gellersen HM; Kedzior KK
    BMC Psychiatry; 2019 May; 19(1):139. PubMed ID: 31064328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: a randomized sham controlled study.
    Praharaj SK; Ram D; Arora M
    J Affect Disord; 2009 Oct; 117(3):146-50. PubMed ID: 19178948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep transcranial magnetic stimulation for adolescents with treatment-resistant depression: A preliminary dose-finding study exploring safety and clinical effectiveness.
    Thai M; Nair AU; Klimes-Dougan B; Albott CS; Silamongkol T; Corkrum M; Hill D; Roemer JW; Lewis CP; Croarkin PE; Lim KO; Widge AS; Nahas Z; Eberly LE; Cullen KR
    J Affect Disord; 2024 Jun; 354():589-600. PubMed ID: 38484878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral prefrontal rTMS and theta burst TMS as an add-on treatment for depression: a randomized placebo controlled trial.
    Prasser J; Schecklmann M; Poeppl TB; Frank E; Kreuzer PM; Hajak G; Rupprecht R; Landgrebe M; Langguth B
    World J Biol Psychiatry; 2015 Jan; 16(1):57-65. PubMed ID: 25430687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.
    Dell'Osso B; Mundo E; D'Urso N; Pozzoli S; Buoli M; Ciabatti M; Rosanova M; Massimini M; Bellina V; Mariotti M; Altamura AC
    Bipolar Disord; 2009 Feb; 11(1):76-81. PubMed ID: 19133969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder.
    Kim DR; Wang E; McGeehan B; Snell J; Ewing G; Iannelli C; O'Reardon JP; Sammel MD; Epperson CN
    Brain Stimul; 2019; 12(1):96-102. PubMed ID: 30249416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant effects of prolonged intermittent theta-burst stimulation monotherapy at the bilateral dorsomedial prefrontal cortex for medication and standard transcranial magnetic stimulation-resistant major depression: a three arm, randomized, double blind, sham-controlled pilot study.
    Cheng CM; Li CT; Jeng JS; Chang WH; Lin WC; Chen MH; Bai YM; Tsai SJ; Su TP
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1433-1442. PubMed ID: 36484844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
    Mantovani A; Pavlicova M; Avery D; Nahas Z; McDonald WM; Wajdik CD; Holtzheimer PE; George MS; Sackeim HA; Lisanby SH
    Depress Anxiety; 2012 Oct; 29(10):883-90. PubMed ID: 22689290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment-Resistant Bipolar Depression.
    Zengin G; Topak OZ; Atesci O; Culha Atesci F
    Psychiatr Danub; 2022; 34(2):236-244. PubMed ID: 35772133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): a 6-month, open label, follow-up study.
    Rapinesi C; Curto M; Kotzalidis GD; Del Casale A; Serata D; Ferri VR; Di Pietro S; Scatena P; Bersani FS; Raccah RN; Digiacomantonio V; Ferracuti S; Bersani G; Zangen A; Angeletti G; Girardi P
    J Affect Disord; 2015 Mar; 174():57-63. PubMed ID: 25484178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment.
    Girardi P; Rapinesi C; Chiarotti F; Kotzalidis GD; Piacentino D; Serata D; Del Casale A; Scatena P; Mascioli F; Raccah RN; Brugnoli R; Digiacomantonio V; Ferri VR; Ferracuti S; Zangen A; Angeletti G
    World J Biol Psychiatry; 2015 Jan; 16(1):66-73. PubMed ID: 25140585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive Transcranial Magnetic Stimulation in Alcohol Dependence: A Randomized, Double-Blind, Sham-Controlled Proof-of-Concept Trial Targeting the Medial Prefrontal and Anterior Cingulate Cortices.
    Harel M; Perini I; Kämpe R; Alyagon U; Shalev H; Besser I; Sommer WH; Heilig M; Zangen A
    Biol Psychiatry; 2022 Jun; 91(12):1061-1069. PubMed ID: 35067356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review.
    Kedzior KK; Gerkensmeier I; Schuchinsky M
    BMC Psychiatry; 2018 May; 18(1):137. PubMed ID: 29776355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
    Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
    J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of transcranial magnetic stimulation in treatment-resistant depression.
    Akpınar K; Oğuzhanoğlu NK; Uğurlu TT
    Turk J Med Sci; 2022 Aug; 52(4):1344-1354. PubMed ID: 36326400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-frequency repetitive transcranial magnetic stimulation (rTMS) improves neurocognitive function in bipolar disorder.
    Yang LL; Zhao D; Kong LL; Sun YQ; Wang ZY; Gao YY; Li N; Lu L; Shi L; Wang XY; Wang YM
    J Affect Disord; 2019 Mar; 246():851-856. PubMed ID: 30795490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do bipolar disorder soft signs impact outcomes following Transcranial Magnetic Stimulation (TMS) therapy for depression?
    Bennett E; Almeida JRC; Carpenter LL
    J Affect Disord; 2019 Feb; 245():237-240. PubMed ID: 30414554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.
    Levkovitz Y; Harel EV; Roth Y; Braw Y; Most D; Katz LN; Sheer A; Gersner R; Zangen A
    Brain Stimul; 2009 Oct; 2(4):188-200. PubMed ID: 20633419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.